Addition of cell suspension transplantation to UVB and topical treatment in non‐segmental vitiligo: a randomized controlled study

International Journal of DermatologyVolume 63, Issue 1 p. e4-e6 Correspondence Addition of cell suspension transplantation to UVB and topical treatment in non-segmental vitiligo: a randomized controlled study Sanne E. Uitentuis MD, PhD, Corresponding Author Sanne E. Uitentuis MD, PhD [email protected] orcid.org/0000-0002-6031-2116 Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorJanny E. Lommerts MD, PhD, Janny E. Lommerts MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorMarcella Willemsen MSc, Marcella Willemsen MSc Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorKarina Willemsen, Karina Willemsen Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorMenno A. de Rie MD, PhD, Menno A. de Rie MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorRosalie M. Luiten PhD, Rosalie M. Luiten PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorMarcel W. Bekkenk MD, PhD, Marcel W. Bekkenk MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorAlbert Wolkerstorfer MD, PhD, Albert Wolkerstorfer MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this author Sanne E. Uitentuis MD, PhD, Corresponding Author Sanne E. Uitentuis MD, PhD [email protected] orcid.org/0000-0002-6031-2116 Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorJanny E. Lommerts MD, PhD, Janny E. Lommerts MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorMarcella Willemsen MSc, Marcella Willemsen MSc Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorKarina Willemsen, Karina Willemsen Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorMenno A. de Rie MD, PhD, Menno A. de Rie MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorRosalie M. Luiten PhD, Rosalie M. Luiten PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorMarcel W. Bekkenk MD, PhD, Marcel W. Bekkenk MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this authorAlbert Wolkerstorfer MD, PhD, Albert Wolkerstorfer MD, PhD Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam Institute for Infection and Immunity, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the NetherlandsSearch for more papers by this author First published: 15 November 2023 https://doi.org/10.1111/ijd.16900 Conflict of interest: None. Funding source: A.W. received a research grant from Avita Medical. S.U. was supported by this research grant. The harvesting devices were provided by Avita Medical. Outside the submitted work A.W. reports grants from Novartis, Incyte, and Lumenis. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Mulekar SV. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Arch Dermatol. 2004; 140: 1211–1215. 10.1001/archderm.140.10.1211 PubMedWeb of Science®Google Scholar 2Van Geel N, Wallaeys E, Goh BK, De Mil M, Lambert J. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus. Br J Dermatol. 2010; 163: 1186–1193. 10.1111/j.1365-2133.2010.10014.x CASPubMedWeb of Science®Google Scholar 3Verma R, Grewal RS, Chatterjee M, Pragasam V, Vasudevan B, Mitra D. A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo. Med J Armed Forces India. 2014; 70: 26–31. 10.1016/j.mjafi.2013.09.004 PubMedGoogle Scholar 4Kachhawa D, Rao P, Kalla G. Simplified non-cultured non-trypsinised epidermal cell graft technique followed by psoralen and ultraviolet a light therapy for stable vitiligo. J Cutan Aesthet Surg. 2017; 10: 81–85. 10.4103/JCAS.JCAS_119_16 PubMedGoogle Scholar 5El-Zawahry BM, Zaki NS, Bassiouny DA, Sobhi RM, Zaghloul A, Khorshied MM, et al. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo. J Eur Acad Dermatol Venereol. 2011; 25: 215–220. 10.1111/j.1468-3083.2010.03759.x CASPubMedWeb of Science®Google Scholar Volume63, Issue1January 2024Pages e4-e6 ReferencesRelatedInformation